{"id":"doi:10.1056/nejmoa2301972","kind":"article","title":"Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial","authors":["Ania M. Jastreboff","Lee M. Kaplan","Juan P. Frías","Qiwei Wu","Yu Du","Sirel Gurbuz","Tamer Coşkun","Axel Haupt","Zvonko Miličević","Mark L. Hartman"],"author_count":10,"year":2023,"published":"2023-06-26","venue":"New England Journal of Medicine","cited_by":1171,"doi":"10.1056/nejmoa2301972","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2301972","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2301972","updated":null,"pmid":"37366315","pmcid":null,"openalex_id":"W4382049661","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}